By: Alaskan Outlaw

As of yesterday (12/15/2021) in Juneau, Alaska. The first case of “adverse reaction” to the Pfizer/BioNtech vaccine that was recently received by the State of Alaska, was noted and relayed to other clinics throughout the state. The first group of people to receive the vaccine were the front-line health care workers, whereas one worker experienced an anaphylactic reaction to the vaccine. The afflicted employee noticed a shortness of breath and “flushing” within the recommended fifteen (15) minute observation period.

The healthcare worker first attempted to counteract the reaction by using OTC Benedryl, and when that didn’t work, they were admitted into the Emergency Department at the local hospital. Prior to this reaction, the healthcare worker reported no known allergies, which, although this reaction shouldn’t be systematic, is being monitored by the Centers for Disease Control and Prevention (CDC), and local health officials. Upon admittance, the patient was administered Pepcid, additional Benedryl, and epinephrine, and is now stable and recovering.

Ultimately, ALL medicines have the potential for adverse reactions is all part of managing the chemical balance within the human body, which really depends on many different factors.

The take-away from this is that any clinic that is authorized to administer the vaccine has been supplied with the required medications to counteract a possible adverse reaction like witnessed in this case. The ability for medical teams to react, and create an optimal recovery situation.

To read the full story, see the Anchorage Press’s story.

Posted on: December 16, 2020, by : Mark Weisman